Education
About Us
Working with TipRanks
Follow Us
GlucoTrack (GCTK)
NASDAQ:GCTK
GCTK Stock Chart & Stats
$6.29
-$0.02(-10.45%)
At close: 4:00 PM EST
$6.29
-$0.02(-10.45%)
Day’s Range― - ―
52-Week Range$4.22 - $469.03
Previous Close$0.14
Volume195.77M
Average Volume (3M)2.54M
Market Cap
$5.54M
Enterprise Value-$6.32M
Total Cash (Recent Filing)$9.55M
Total Debt (Recent Filing)$267.00K
Price to Earnings (P/E)―
Beta1.52
Next Earnings
Apr 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.64
Shares Outstanding910,688
10 Day Avg. Volume100,775
30 Day Avg. Volume2,541,249
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-12.81
Price to Sales (P/S)0.00
P/FCF Ratio-13.22
Enterprise Value/Market Cap-1.14
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit147.00
Enterprise Value/Ebitda0.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GlucoTrack News
GCTK FAQ
What was GlucoTrack’s price range in the past 12 months?
GlucoTrack lowest stock price was $4.22 and its highest was $469.03 in the past 12 months.
What is GlucoTrack’s market cap?
GlucoTrack’s market cap is $5.54M.
When is GlucoTrack’s upcoming earnings report date?
GlucoTrack’s upcoming earnings report date is Apr 06, 2026 which is in 123 days.
How were GlucoTrack’s earnings last quarter?
GlucoTrack released its earnings results on Nov 13, 2025. The company reported -$4.638 earnings per share for the quarter, missing the consensus estimate of N/A by -$4.638.
Is GlucoTrack overvalued?
According to Wall Street analysts GlucoTrack’s price is currently Overvalued.
Does GlucoTrack pay dividends?
GlucoTrack does not currently pay dividends.
What is GlucoTrack’s EPS estimate?
GlucoTrack’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GlucoTrack have?
GlucoTrack has 910,688 shares outstanding.
What happened to GlucoTrack’s price movement after its last earnings report?
GlucoTrack reported an EPS of -$4.638 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.642%.
Which hedge fund is a major shareholder of GlucoTrack?
Currently, no hedge funds are holding shares in GCTK
Company Description
GlucoTrack
GlucoTrack (GCTK) is a medical technology company specializing in the development and commercialization of innovative glucose monitoring devices. The company focuses on providing non-invasive solutions for individuals managing diabetes, aiming to enhance their quality of life through advanced technology. GlucoTrack's core product is a non-invasive glucose measurement device designed to offer an alternative to traditional finger-stick testing, thus providing a more comfortable and convenient monitoring experience for users.
Technical Analysis
EKSO BIONICS
―
Predictive Oncology
―
Femasys
―
Meihua International Medical Technologies Co., Ltd.
―
WORK Medical Technology Group LTD
―